Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc. (MPLT), sold 45,422 shares at $28.96 ($1.3M) on 2026-04-27, disclosed to the SEC on 2026-04-29.
Scheduled sale ($1.3M) by Chief Discovery Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.96 | 8,346 | $242K | 17.9% |
| 2 | $29.63 | 29,255 | $867K | 64.3% |
| 3 | $30.50 | 7,821 | $239K | 17.7% |
| Total | $29.66 avg | 45,422 | $1.3M | 100% |
| Filing → |
| MPLT | SELL | 2026-04-17 | $88K | — | Filing → |